Cordis US Executive and Leadership Team

Duke Rohlen, the Chief Executive Officer at Cordis US, directs the overarching strategic vision for the development of interventional cardiovascular technologies. By overseeing the integration of research and manufacturing, the Chief Executive Officer ensures the delivery of high-quality guidewires, catheters, and stents to global markets. This leadership role involves constant collaboration with the Board to maintain market leadership in vascular closure systems. Duke Rohlen drives the company mission by prioritizing innovation in minimally invasive devices, which directly impacts the treatment of coronary and peripheral vascular diseases. Through rigorous oversight of corporate performance, the Chief Executive Officer secures long-term growth and operational efficiency. By fostering a culture of clinical excellence, Rohlen maintains the competitive edge of the organization within the complex medical device landscape, ensuring that every product meets the highest standards of safety and efficacy for patients worldwide.

Hernan Domenico, the Chief Financial Officer & Head of Finance (Americas) at Cordis US, manages the fiscal health and capital allocation strategies across the North and South American markets. Overseeing financial planning and analysis, the Chief Financial Officer & Head of Finance (Americas) ensures that resource distribution aligns with the manufacturing requirements for cardiovascular devices. This role involves managing complex budgetary frameworks to support the production of stents and vascular closure systems. Hernan Domenico drives financial transparency and accountability, providing the necessary data for strategic decision-making at the executive level. By optimizing cost structures and revenue streams, the Chief Financial Officer & Head of Finance (Americas) strengthens the regional market position. Domenico secures the financial stability required for sustained investment in medical technology, ensuring that the company maintains its commitment to treating vascular diseases while achieving robust growth targets throughout the Americas.

Matthew Muscari, the President, Americas at Cordis US, directs all commercial operations and market penetration strategies for the North and South American regions. Overseeing the distribution of interventional cardiovascular technologies, the President, Americas ensures that hospitals and clinics receive essential devices like balloons and stents to treat vascular diseases. This leadership role involves managing regional sales teams and fostering relationships with key clinical stakeholders. Matthew Muscari drives the adoption of minimally invasive solutions, which directly impacts the company's market share in the Americas. By aligning regional sales efforts with the broader manufacturing capabilities of the organization, the President, Americas optimizes the supply chain for maximum impact. Muscari secures consistent revenue growth by identifying emerging clinical needs and ensuring that the product portfolio addresses the specific requirements of the regional healthcare landscape, thereby reinforcing the company's reputation for excellence in cardiovascular care.

Bryan Loo, the President, Asia Pacific at Cordis US, directs the expansion and commercial strategy for the company across the diverse Asia Pacific healthcare markets. Overseeing the regional implementation of interventional cardiovascular technologies, the President, Asia Pacific ensures that advanced devices such as guidewires and vascular closure systems reach patients in need. This leadership role involves navigating complex regulatory environments and building strategic partnerships with regional medical institutions. Bryan Loo drives the growth of the product portfolio, which directly impacts the treatment of peripheral vascular diseases throughout the region. By coordinating with global manufacturing teams, the President, Asia Pacific ensures that the supply chain meets the specific demands of the Asia Pacific market. Loo secures long-term success by adapting the company's clinical solutions to local healthcare standards, thereby expanding the reach of the organization and enhancing the quality of cardiovascular care across the entire region.

Nancy Pounder, the Chief Human Resources Officer at Cordis US, architects the talent acquisition and organizational development strategies necessary to support a global medical-device manufacturer. Overseeing workforce planning, the Chief Human Resources Officer ensures that the company attracts top-tier engineering and clinical talent to advance the development of catheters and guidewires. This leadership role involves cultivating a high-performance culture that aligns with the mission of improving patient outcomes. Nancy Pounder drives employee engagement and professional development programs, which directly impact the operational efficiency of the manufacturing teams. By managing complex human capital requirements, the Chief Human Resources Officer supports the broader business objectives of the organization. Pounder ensures that the workforce remains agile and capable of meeting the evolving demands of the cardiovascular technology sector, ultimately fostering an environment where innovation thrives and the company maintains its status as a leader in medical device manufacturing.